Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Incidence of Ocular Inflammation as Defined by the Inflammadry Assay in 250 Consecutive Cataract Patients and Their Response to Treatment With Xiidra

NCT04120987 is registered in ClinicalTrials.gov with Bucci Laser Vision Institute as lead sponsor.

NCT NCT04120987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04120987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Incidence of Ocular Inflammation as Defined by the Inflammadry Assay in 250 Consecutive Cataract Patients and Their Response to Treatment With Xiidra
Lead sponsor
Bucci Laser Vision Institute
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2021
Completion date
June 25, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye